- Home
- CRBU vs AMRN Comparison
CRBU vs AMRN Comparison
Compare CRBU & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- AMRN
- Stock Information
- Founded
- CRBU 2011
- AMRN 1989
- Country
- CRBU United States
- AMRN Ireland
- Employees
- CRBU N/A
- AMRN N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- CRBU Health Care
- AMRN Health Care
- Exchange
- CRBU Nasdaq
- AMRN Nasdaq
- Market Cap
- CRBU 188.8M
- AMRN 216.0M
- IPO Year
- CRBU 2021
- AMRN 1993
- Fundamental
- Price
- CRBU $1.90
- AMRN $15.05
- Analyst Decision
- CRBU Strong Buy
- AMRN Strong Sell
- Analyst Count
- CRBU 4
- AMRN 1
- Target Price
- CRBU $8.50
- AMRN $12.00
- AVG Volume (30 Days)
- CRBU 1.8M
- AMRN 74.7K
- Earning Date
- CRBU 08-12-2025
- AMRN 07-30-2025
- Dividend Yield
- CRBU N/A
- AMRN N/A
- EPS Growth
- CRBU N/A
- AMRN N/A
- EPS
- CRBU N/A
- AMRN N/A
- Revenue
- CRBU $9,918,000.00
- AMRN $219,361,000.00
- Revenue This Year
- CRBU $9.52
- AMRN N/A
- Revenue Next Year
- CRBU N/A
- AMRN N/A
- P/E Ratio
- CRBU N/A
- AMRN N/A
- Revenue Growth
- CRBU N/A
- AMRN N/A
- 52 Week Low
- CRBU $0.66
- AMRN $7.08
- 52 Week High
- CRBU $3.00
- AMRN $17.49
- Technical
- Relative Strength Index (RSI)
- CRBU 53.41
- AMRN 48.53
- Support Level
- CRBU $1.86
- AMRN $14.05
- Resistance Level
- CRBU $2.13
- AMRN $15.50
- Average True Range (ATR)
- CRBU 0.22
- AMRN 0.64
- MACD
- CRBU -0.05
- AMRN -0.15
- Stochastic Oscillator
- CRBU 15.76
- AMRN 47.17
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.